The Forward P/E of Emmaus Life Sciences Inc (EMMA) is 0.30.
Forward P/E estimates how much investors are willing to pay today for each dollar of a company's expected future earnings. It serves as a valuation tool based on projected profitability rather than past performance.
| Ticker | Name | Value |
|---|---|---|
| CPH.TO | Cipher Pharmaceuticals Inc | 14.03 |
| RX.V | Biosyent Inc | 12.91 |
| TIUM.U.CN | Cansortium Inc | 1.35 |